Open AccessJournal Article
Expert consensus document on arterial stiffness : methodological issues and clinical applications. Commentary
Michael F. O'Rourke,Stanley S. Franklin,Stéphane Laurent,John R. Cockcroft,Luc M. Van Bortel,Pierre Boutouyrie,Cristina Giannattasio,Daniel Hayoz,Bruno Pannier,Charalambos Vlachopoulos,Ian B. Wilkinson,Harry A.J. Struijker-Boudier +11 more
Reads0
Chats0
TLDR
In this paper, the authors summarized the proceedings of several meetings of the European Network for Non-invasive Investigation of Large Arteries and aimed at providing an updated and practical overview of the most relevant methodological aspects and clinical applications in this area.Abstract:
In recent years, great emphasis has been placed on the role of arterial stiffness in the development of cardiovascular diseases. Indeed, the assessment of arterial stiffness is increasingly used in the clinical assessment of patients. Although several papers have previously addressed the methodological issues concerning the various indices of arterial stiffness currently available, and their clinical applications, clinicians and researchers still report difficulties in selecting the most appropriate methodology for their specific use. This paper summarizes the proceedings of several meetings of the European Network for Non-invasive Investigation of Large Arteries and is aimed at providing an updated and practical overview of the most relevant methodological aspects and clinical applications in this area.read more
Citations
More filters
Journal ArticleDOI
Age-Associated Increase in Arterial Stiffness Measured According to the Cardio-Ankle Vascular Index without Blood Pressure Changes in Healthy Adults
TL;DR: The data suggest that the CAVI is a sensitive marker of the arterial aging process, above and beyond conventional upper arm BP.
Journal ArticleDOI
Arterial wall dysfunction in systemic lupus erythematosus.
A. Cypiene,M. Kovaite,Algirdas Venalis,J. Dadoniene,Rita Rugiene,Zaneta Petrulioniene,Ligita Ryliskyte,Aleksandras Laucevičius +7 more
TL;DR: Control for mean blood pressure and taking measures towards organ damage prevention can partially slow down the process of early atherosclerosis in SLE patients, regardless of the small number of study group patients.
Journal ArticleDOI
Arterial stiffness: a modifiable cardiovascular risk factor?
TL;DR: Although aortic stiffening with age is attributable to fracture of elastin lamellae and is largely irreversible, stiffening of muscular arteries can be modified by vasodilator drugs, and by improved endothelial function such as induced by exercise training.
Journal ArticleDOI
Central Arterial Stiffness Is Associated With Structural Brain Damage and Poorer Cognitive Performance: The ARIC Study.
Priya Palta,A. Richey Sharrett,A. Richey Sharrett,Jingkai Wei,Michelle L. Meyer,Anna Kucharska-Newton,Melinda C. Power,Jennifer A. Deal,Jennifer A. Deal,Clifford R. Jack,David S. Knopman,Jacqueline C. Wright,Jacqueline C. Wright,Michael Griswold,Hirofumi Tanaka,Thomas H. Mosley,Gerardo Heiss +16 more
TL;DR: Central arterial hemodynamics were associated with structural brain damage and poorer cognitive performance among older adults and the difference in log‐transformed volumes of white matter hyperintensities, total brain, and the Alzheimer disease signature region.
Journal ArticleDOI
Cardiovascular Effects of Phosphodiesterase Type 5 Inhibitors
TL;DR: Accumulating data show that the therapeutic potential of PDE5 inhibition extends to the myocardium, the coronary and peripheral arteries, subliclinical inflammation, oxidative stress, thrombosis, neurological recovery, and pathways of fibrosis, and the spectrum of patients who may benefit has expanded to include, for instance, patients with heart failure or coronary artery disease.
References
More filters
Journal ArticleDOI
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
Aram V. Chobanian,George L. Bakris,Henry R. Black,William C. Cushman,Lee A. Green,Joseph L. Izzo,Daniel W. Jones,Barry J. Materson,Suzanne Oparil,Jackson T. Wright,Edward J. Roccella +10 more
TL;DR: The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated, and empathy builds trust and is a potent motivator.
Journal ArticleDOI
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Aram V. Chobanian,George L. Bakris,Henry R. Black,William C. Cushman,Lee A. Green,Joseph L. Izzo,Daniel W. Jones,Barry J. Materson,Suzanne Oparil,Jackson T. Wright,Edward J. Roccella +10 more
TL;DR: In those older than age 50, systolic blood pressure of greater than 140 mm Hg is a more important cardiovascular disease (CVD) risk factor than diastolic BP, and hypertension will be controlled only if patients are motivated to stay on their treatment plan.
Journal ArticleDOI
2007 Guidelines for the Management of Arterial Hypertension : The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Giuseppe Mancia,Guy De Backer,Anna F. Dominiczak,Renata Cifkova,Robert Fagard,Giuseppe Germanò,Guido Grassi,Anthony M. Heagerty,Sverre E. Kjeldsen,Stéphane Laurent,Krzysztof Narkiewicz,Luis M. Ruilope,Andrzej Rynkiewicz,Roland E. Schmieder,Harry A.J. Struijker Boudier,Alberto Zanchetti +15 more
TL;DR: 2007 Guidelines for the Management of Arterial Hypertension : The Task Force for the management of Arterspertension of the European Society ofhypertension (ESH) and of theEuropean Society of Cardiology (ESC).
Journal ArticleDOI
Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients.
Stéphane Laurent,Pierre Boutouyrie,Roland Asmar,Isabelle Gautier,Brigitte Laloux,Louis Guize,Pierre Ducimetière,Athanase Benetos +7 more
TL;DR: This study provides the first direct evidence that aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with essential hypertension.
Journal ArticleDOI
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
Björn Dahlöf,Peter S. Sever,Neil R Poulter,Hans Wedel,D Gareth Beevers,Mark J. Caulfield,Rory Collins,Sverre E. Kjeldsen,Arni Kristinsson,Gordon T. McInnes,Jesper Mehlsen,Markku S. Nieminen,Eoin O'Brien,Jan Östergren +13 more
TL;DR: The amlodipine-based regimen prevented more major cardiovascular events and induced less diabetes than the atenolol- based regimen, and these effects might not be entirely explained by better control of blood pressure.
Related Papers (5)
Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'.
Francesco U.S. Mattace-Raso,Albert Hofman,Germaine C. Verwoert,Jacqueline C.M. Witteman,Ian B. Wilkinson,John R. Cockcroft,Carmel M. McEniery,Yasmin,Stéphane Laurent,Pierre Boutouyrie,Erwan Bozec,Tine W. Hansen,Christian Torp-Pedersen,Hans Ibsen,Hans Ibsen,Jørgen Jeppesen,Sebastian Vermeersch,Ernst Rietzschel,Marc De Buyzere,Thierry C. Gillebert,Luc M. Van Bortel,Patrick Segers,Charalambos Vlachopoulos,Constantinos Aznaouridis,Christodoulos Stefanadis,Athanase Benetos,Athanase Benetos,Carlos Labat,Carlos Labat,Patrick Lacolley,Patrick Lacolley,Coen D.A. Stehouwer,Giel Nijpels,Jacqueline M. Dekker,Isabel Ferreira,Jos W. R. Twisk,Sébastien Czernichow,Pilar Galan,Serge Hercberg,Bruno Pannier,Alain P. Guerin,Gérard M. London,John Kennedy Cruickshank,John Kennedy Cruickshank,Simon G. Anderson,Anna Paini,Enrico Agabiti Rosei,Maria Lorenza Muiesan,Massimo Salvetti,Jan Filipovsky,Jitka Seidlerová,M. Dolejšová +51 more